
Current Clinical Finding: “In this study of patients with type 2 diabetes who had no prior eye disorders, patients prescribed semaglutide or tirzepatide had an increased risk of NAION and other
FREE CASE EVALUATION: (855) 846-6529
"Built for speed, optimized for performance, and engineered for the next generation of tech advancements."
"We advocate for the rights of those without a voice against the powerful and unjust and empower them to fight back against the corporations who harmed them with their defective products, dangerous drugs and misleading statements to shareholders."
“I feel it is my obligation as a lawyer is to advocate for the rights of those without a voice: working people, the sick, the elderly, poor, or the injured, against the powerful and unjust.” – Timothy L. Miles, ESQ.
Timothy L. Miles is a nationally recognized trial lawyer based in Brentwood, TN. His practice is widely known for handling complex cases, including:
Fighting corporate fraud and misleading statements that harm investors and devalue your hard-earned shares.
Holding negligent manufacturers and pharmaceutical giants accountable for injuries caused by defective products and dangerous drugs.
Empowering everyday people to band together and win justice against the most powerful corporations in the world.
Our mission is to provide high-quality legal representation to investors in securities class action lawsuits and other complex litigation.
Our vision is to be the premier law firm for investors seeking justice and accountability from corporations that violate the law.
Have more questions about your case?
Get a Free Case EvaluationWith a quarter-century of experience, Timothy L. Miles has built a reputation for taking on the most complex cases against the world's largest pharmaceutical and insurance corporations.
AV PREEMINENT® RATING
"The Highest Possible Peer Rating for Legal Ability and Ethical Standards since 2014."
Mr. Miles brings a wealth of experience to your case in securities class actions, mass torts, product liability, and dangerous drugs.
Having prosecuted legendary cases alongside the top plaintiffs' lawyers in the country, his 25-year tenure ensures that your Zepbound claim is handled with the highest level of professional skill and strategic insight.
Top 100 Civil Plaintiff Trial Lawyer
AVVO Top-Rated Lawyer
Elite Lawyer of the South
Lawyers of Distinction (2021-2026)

Current Clinical Finding: “In this study of patients with type 2 diabetes who had no prior eye disorders, patients prescribed semaglutide or tirzepatide had an increased risk of NAION and other

Introduction to a Whistleblower Lawsuit in Nashville Welcome to this authoritative guide on a whistleblower lawsuit in Nashville. If you are sitting in Nashville right now with that sinking feeling

Introduction Filing a Nashville whistleblower lawsuit is a courages act by a brave indivdual stepping up to expose fraud against the governemnt. Speaking up about fraud, safety violations, discrimination, or

Introduction to Blowing the Whistle by a Nashvillle Whistleblower Lawyer Wecome to this authoritative guide by a Nashville whistleblower lawyer on blowing the whistle. Speaking up about fraud, safety violations,

Introduction to the Aldeyra Therapeutics Class Action Lawsuit The Aldeyra Therapeutics class action lawsuit covers investors who purchased or acquired Aldeyra securities between November 3, 2023, and March 16, 2026. Captioned Kirby v. Aldeyra Therapeutics,

Introduction to the Pinterest Class Action Lawsuit The Pinterest class action lawsuit seeks to represent purchasers or acquirers of Pinterest, Inc. (NYSE: PINS) securities between February 7, 2025 and February 12, 2026,

Introduction to the Oddity Tech Class Action Lawsuit The Oddity Tech class action lawsuit seeks to represent purchasers or acquirers of Oddity Tech, Ltd. (NASDAQ: ODD) securities between February 26, 2025 and

Introduction to Zepbound Vision Loss Lawsuit If you took Zepbound and suffered vision loss or other serious Zepbound vision problems, including, but not limited to: Nonarteritic Anterior Ischemic Optic Neuropathy

Introduction to the Aldeyra Therapeutics Class Action Lawsuit The Aldeyra Therapeutics class action lawsuit covers investors who purchased or acquired Aldeyra securities between November 3, 2023, and March 16, 2026. Captioned Kirby v. Aldeyra Therapeutics,

Introduction to the Pinterest Class Action Lawsuit The Pinterest class action lawsuit seeks to represent purchasers or acquirers of Pinterest, Inc. (NYSE: PINS) securities between February 7, 2025 and February 12, 2026, inclusive (the “Class Period”).
"Remember one thing, no matter how bad things seem now or how down you may feel, may you take comfort in knowing one thing: Justice Is and Always Will Be Blind to the Love of Profit."
— Timothy L. Miles, Esq. —
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.